BENEVICH ERIC bought NBIX
February 28, 2024 · Form 4 insider transaction
BENEVICH ERIC bought 21,857 shares of Neurocrine Biosciences, Inc. at $79.02 per share, a transaction worth $1.73M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
21,857
Price
$79.02
Total value
$1.73M
InsiderBENEVICH ERIC
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 28, 2024
Filing dateFebruary 29, 2024
Shares owned after62,473
OwnershipDirect
10b5-1 planNo
AmendedNo